Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
May 18 2022 - 08:00AM
GlobeNewswire Inc.
Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on
innovative products for acute care settings, today announced that
Gerri Henwood, the Company’s President and Chief Executive Officer,
will present at the H.C. Wainwright Annual Global Life Sciences
Conference, taking place in Miami, Florida on Wednesday, May 25,
2022, at 1:30 p.m. Eastern Time.
A webcast of the presentation will be available
on the “Events” page within the investors section of the Baudax Bio
website at https://www.baudaxbio.com/news-and-investors. The
webcast will be archived on the company’s website for 90 days
following the event.
About Baudax Bio
Baudax Bio is a pharmaceutical company focused
on innovative products for acute care settings. ANJESO is the first
and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal
anti-inflammatory (NSAID) for the management of moderate to severe
pain. In addition to ANJESO, Baudax Bio has a pipeline of other
innovative pharmaceutical assets including two novel neuromuscular
blocking agents (NMBs) and a proprietary chemical reversal agent
specific to these NMBs. For more information, please visit
www.baudaxbio.com.
CONTACT:
Investor Relations Contact:
Argot PartnersSam Martin / Kaela Ilami(212)
600-1902baudaxbio@argotpartners.com
Media Contact:
Argot PartnersDavid Rosen(212)
600-1902david.rosen@argotpartners.com
Baudax Bio (NASDAQ:BXRX)
Historical Stock Chart
From Jul 2022 to Aug 2022
Baudax Bio (NASDAQ:BXRX)
Historical Stock Chart
From Aug 2021 to Aug 2022